Customized SELEX for Precision Aptamer Development: A Streamlined, Demand-Driven Process Customized SELEX (Systematic Evolution of Ligands by Exponential Enrichment) technology represents a significant advancement over traditional, generic screening methods. This demand-oriented pathway enables the precise development of high-performance aptamers (RNA, DNA, or peptide) by tailoring every step to the specific target and intended application, resulting …

Targeting Peptides: Design, Discovery & Applications Targeting peptides are short chains of amino acids engineered to bind specific cells or molecules with high precision. Valued for their superior tissue penetration, low immunogenicity, and ease of chemical modification, they are powerful tools in modern biomedicine for targeted drug delivery, diagnostic imaging, and therapeutic intervention. Their development …

Advancing Aptamer Discovery: How SELEX Sequencing Transforms Biomolecular Screening The systematic evolution of ligands by exponential enrichment (SELEX) is a powerful in vitrotechnique for discovering nucleic acid aptamers—synthetic molecules that bind specific targets with antibody-like precision. By iteratively screening vast random-sequence libraries, SELEX isolates high-affinity, high-specificity aptamers for diverse targets, including proteins, small molecules, and …

Literature Analysis (IF 45.8) | Advanced CAR-T Therapy & Peptide Screening Services – Accelerate Cancer Immunotherapy R&D CAR-T therapy harnesses the body’s own T cells to target and destroy cancer cells. In this approach, a patient’s T cells are engineered to express a chimeric antigen receptor (CAR) that recognizes specific antigens on cancer cells, enabling …

Literature Analysis (IF 13.7) | AI-Powered Precision Design of Macrocyclic Peptides: Cracking the Code of “Undruggable” Targets Traditional peptide drug discovery faces major hurdles: heavy reliance on random screening of vast libraries or natural products, inefficient high-throughput processes, and an inability to rationally design stable, high-affinity macrocyclic peptides for “undruggable” targets lacking deep binding pockets. …

CRISPR Cell Lines: A Guide to Gene Editing and Applications CRISPR/Cas9 is a gene-editing system derived from bacterial immunity, enabling precise genome cleavage in eukaryotic cells. It consists of sgRNA, which targets specific DNA sequences via base pairing, and the Cas9 nuclease, which cuts DNA near a PAM site. Cells repair Cas9-induced double-strand breaks via …

Navigating the Dodecapeptide Library: A Guide to High-Affinity Ligand Discovery A dodecapeptide library consists of all possible 12-amino-acid peptides, chemically synthesized and displayed on phage particles. It is crucial for molecular recognition, drug target discovery, and diagnostic/therapeutic tool development. Selected peptides can act as probes for target binding sites or as lead compounds for drug …

The Dodecapeptide Phage Display Library: A Comprehensive Guide Background Phage display, introduced by Smith in 1985, fuses foreign peptides to the pIII coat protein of filamentous phage. This allows peptide presentation on the phage surface while preserving infectivity, enabling specific molecular recognition. Dodecapeptide (12-mer) libraries represent a major advance over shorter peptides. The increased length …

Essential Cell Culture Techniques: A Guide to Sterile Practice & Routine Protocol I. Cell Culture Basics & Lab Setup Cell culture replicates the in vivo environment in vitro, providing essential conditions: temperature, gas, pH, and nutrient-rich medium. A functional lab requires separate zones for reagent prep, buffering, and aseptic work. The biosafety cabinet provides sterile …

Heptapeptide Libraries: A High-Throughput Path to Drug Discovery I. Overview Heptapeptide libraries are key combinatorial tools for discovering bioactive ligands. Their moderate length offers structural diversity, while the physical linkage between peptide phenotype and genotype enables rapid identification of high-affinity binders to specific targets via high-throughput screening. This efficiently generates leads for biopharmaceutical development. II. …